Old Web
English
Sign In
Acemap
>
authorDetail
>
Saravanan Kumar
Saravanan Kumar
Thermo Fisher Scientific
Biology
Cancer research
Multiple myeloma
Bortezomib
Metabolomics
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparative analysis of homologous aminopeptidase PepN from pathogenic and non-pathogenic mycobacteria reveals divergent traits
2019
PLOS ONE
Nishant Sharma
Suruchi Aggarwal
Saravanan Kumar
Rahul Sharma
Konika Choudhury
Niti Singh
Praapti Jayaswal
Renu Goel
Saima Wajid
Amit Kumar Yadav
Krishnamohan Atmakuri
Show All
Source
Cite
Save
Citations (1)
Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma
2019
Current Topics in Medicinal Chemistry
Venkatesh Chanukuppa
Ravindra Taware
Tathagat Chatterjee
Sanjeevan Sharma
Tushar H. More
Khushman Taunk
Saravanan Kumar
Manas Kumar Santra
Srikanth Rapole
Show All
Source
Cite
Save
Citations (4)
XPO1 is a critical player for bortezomib resistance in multiple myeloma: A quantitative proteomic approach
2019
Journal of Proteomics
Venkatesh Chanukuppa
Debasish Paul
Khushman Taunk
Tathagata Chatterjee
Sanjeevan Sharma
Saravanan Kumar
Manas Kumar Santra
Srikanth Rapole
Show All
Source
Cite
Save
Citations (15)
1